Although BRCAm carriers are more likely to have a poor response to ovarian stimulation [7], Grynberg at al. have recently shown that BRCA1/2 pathogenic variants do not seem to affect the capacity of oocytes to mature in vitro in breast cancer patients candidate for fertility preservation [26]. This evidence concerns the gene BRCA1 and breast carcinoma.